Suvorexant and Sleep/Delirium in ICU Patients

NCT04092894 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Insomnia
Sleep Fragmentation
Sleep Initiation and Maintenance Disorders
Postoperative Delirium

Interventions

DRUG: Suvorexant 20 mg
DRUG: Placebo oral tablet

Sponsor

Beth Israel Deaconess Medical Center

Collaborators

[object Object]